Combined radioguided occult lession and sentinel node localization for breast cancer

ANZ Journal of Surgery

Volumn 74, Issue 7, 2004, Pages 550-553

  Kim, Joon ^a   Chung, David ^d   Spillane, Andrew ^a,b,c,e  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Mater Hospital   (Australia)

^c St Lukes Hospital   (Australia)

^d Nucl Med and Diagnostic Ultrasound   (Australia)

^e SYDNEY CANCER CENTRE   (Australia)

Author keywords

Breast cancer; Radioguided localization; Sentinel node biopsy

Indexed keywords

TECHNETIUM 99M; TRACER;

ACCURACY; ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST LESION; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL ARTICLE; HUMAN; PREOPERATIVE PERIOD; RADIOACTIVITY; RADIOLOGICAL PROCEDURES; RELIABILITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; ULTRASOUND;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 3442895686     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2004.03057.x     Document Type: Article

References (35)

1. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening. Arch. Surg. 1996; 131: 301-8.
2. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 1998; 352: 930-42.
3. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992; 339: 71-85.
4. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancer 1998; 351: 1451-67.
5. NIH Consensus statement. Adjuvant Therapy for Breast Cancer, November 1-3, 2000; 17: No. 4. Available from: http://consensus. nih.gov/cons/114/ 114_intro.htm.
6. Veronesi U, Paganelli G, Galimberti V et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-7.
7. Guiliano AE, Dale PS, Roderick R, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann. Surg. 1995; 222: 394-401.
8. Krag DN, Weaver DL, Alex JC et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using gamma probe. Surg. Oncol. 1993; 2: 335-40.
9. Kelly P, Winslow E. Needle wire localisation for non-palpable breast lesions: sensations, anxiety levels and informational needs. Onc. Nurs. Forum 1996; 23: 639-45.
10. Van Susante JL, Barendregt WB, Bruggink ED. Migration of the guide-wire into the pleural cavity after needle localisation of breast lesions. Eur. J. Surg. Oncol. 1998; 24: 446-8.
11. Kaufman C, Jacobson L, Bachman B, Kaufman L. Intraoperative ultrasound facilitates surgery for early breast cancer. Ann. Surg. Oncol. 2002; 9: 988-93.
12. Di Giorgio A, Arnone P, Canavese A. Ultrasound guided excisional biopsy of non-palpable breast lesions: technique and preliminary results. Eur. J. Surg. 1998; 164: 819-24.
13. Arman A, Kilicoglu G, Hatipoglu Guner H et al. Marking of nonpalpable breast lesions using a custom carbon suspension. Acta Radiol. 2001; 42: 599-601.
14. Svane G. A stereotactic technique for preoperative marking of non-palpable breast lesions. Acta Radiol. Diag. 1983; 24: 145-51.
15. Gennari R, Galimberti V, De Cicco C et al. Use of technetium-99m-labelled colloid albumin for preoperative and intraoperative localisation of occult breast lesions. J. Am. Coll. Surg. 2000; 190: 692-9.
16. Zurrida S, Galimberti V, Monti S, Luini A. Radioguided localisation of occult breast lesions. Breast 1998; 7: 11-13.
17. De Cicco C, Pizzamiglio M, Trifiro G et al. Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer -technical aspects. Quart J. Nucl. Med. 2002; 46: 145-51.
18. Barros A, Cardosa MA, Sheng PY et ed. Radioguided localisation of non-palpable breast lesions and simultaneous sentinel lymph node mapping. Eur. J. Nucl. Med. Mol Imaging 2002; 29: 1561-5.
19. Feggi L, Basaglia E, Corcione S et al. An original approach in the diagnosis of early breast cancer: use of the same radio- pharmaceutical for both non-palpbale lesions and sentinel node localisation. Eur. J. Nucl. Med. 2001; 20: 1589-96.
20. Gray RJ, Giuliano R, Dauway EL et al. Radioguidance for non- palpable primary lesions and sentinel lymph nodes. Am. J. Surg. 2001; 182: 404-6.
21. Uren RF, Howman-Giles RB, Thompson JF et al. Mammary lymphoscintigraphy in breast cancer. J. Nucl. Med. 1995; 36: 1775-80.
22. Uren RF, Thompson JF, Howman-Giles RB. Lymphatic Drainage of the Skin and Breast. The Netherlands: Harwood Academic Publishers, 1999.
23. Kollias J, Gill G, Chatterton B et al. Sentinel node biopsy in breast cancer. Recommendations for surgeons, pathologist nuclear physicians and radiologists in Australia and New Zealand. Aust. N. Z. J. Surg. 2000; 70: 132-6.
24. Ross M. Sentinel node dissection in early stage breast cancer: Ongoing prospective randomised trials in the USA Ann. Surg. Oncol. 2001; 8: 77S-81S.
25. Tafra L, Lannin DR, Swanson MS et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulphur colloid and isosulfan blue dye. Ann. Surg. 2001; 233: 51-9.
26. Gisvold J, Martin J. Prebiopsy localisation of nonpalpable breast lesions. AJR 1979; 143: 477.
27. Hall F, Frank H. Preoperative localisation of nonpalpable breast lesions. AJR 1973; 132: 101.
28. Homer MJ, Smith TJ, Safaii H. Prebiopsy needle localisation methods, problems and expected results. Radial. Clin. Nth Am. 1992; 30: 139.
29. Rahusen F, Bremers A, Fabry H et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomised clinical trial. Ann. Surg. Oncol. 2002; 9: 994-8.
30. Kaufman CS, Delbecq R, Jacobson L. Excising the re-excision: stereotactic core-needle biopsy decreases need for re-excision of breast cancer. World J. Surg. 1998; 22: 1023-7.
31. Allen MJ, Thompson WD, Stuart RC et al. Management of non- palpable breast lesions detected mammographically. Br. J. Surg. 1994; 81: 543-5.
32. Luini A, Zurrida S, Paganelli G et al. Comparison of radioguided excision with wire localisation of occult lesions. Br. J. Surg. 1999; 86: 522-5.
33. Mullen DJ, Eisen RN, Newman RD, Perrone PM, Wilsey JC. The use of carbon marking after stereotactic large-core-needle breast biopsy. Radiology 2001; 218: 255-60.
34. Cremonesi M, Ferrari M, Sacco E et al. Radiation protection in radioguided surgery of breast cancer. Nucl. Med. Commun 1999; 20: 919-24.
35. International Commission of Radiological Protection. International Commission of Radiological Protection. Publication 60. Oxford: Pergamon Press, 1991.